Aucta patents expiration
1. Motpoly Xr patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11337943 | AUCTA | Lacosamide pharmaceutical composition and dosage form thereof |
Jun, 2040
(16 years from now) | |
Drugs and Companies using LACOSAMIDE ingredient
Market Authorisation Date: 04 May, 2023
Treatment: Treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
MOTPOLY XR family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic